Korean J Urol.  2011 Sep;52(9):589-597.

Current Concepts in Bacterial Sexually Transmitted Diseases

• Shim BS

Abstract

Sexually transmitted diseases (STDs) are the most common infectious diseases worldwide, with over 350 million new cases occurring each year, and have far-reaching health, social, and economic consequences. Failure to diagnose and treat STDs at an early stage may result in serious complications and sequelae. STDs are passed from person to person primarily by sexual contact and are classified into varied groups. Some cause mild, acute symptoms and some are life-threatening. They are caused by many different infectious organisms and are treated in different ways. Syphilis and gonorrhea are ancient afflictions. Now, however, Chlamydia is prevalent and has become the most common bacterial STD. Antimicrobial resistance of several sexually transmitted pathogens is increasing, rendering some regimens ineffective, adding to therapeutic problems. A standardized treatment protocol for STDs is recommended to ensure that all patients receive adequate treatment. Appropriate treatment of STDs is an important public health measure.

Keyword

Chancroid; Chlamydia; Gonorrhea; Sexually transmitted diseases; Syphilis

MeSH Terms

Chancroid
Chlamydia
Clinical Protocols
Communicable Diseases
Dietary Sucrose
Gonorrhea
Humans
Public Health
Sexually Transmitted Diseases
Sexually Transmitted Diseases, Bacterial
Syphilis
Dietary Sucrose

Reference

1. Aral S, Over M, Manhart L, Holmes KK. Jamison D, Evans D, Alleyne G, Jha P, Breman J, Measham A, editors. Sexually transmitted infections. Disease control priorities in developing countries. 2006. Washington, D.C: World Bank and Oxford University Press;p. 311–330.

2. Wellings K, Collumbien M, Slaymaker E, Singh S, Hodges Z, Patel D, et al. Sexual behaviour in context: a global perspective. Lancet. 2006; 368:1706–1728. PMID: 17098090.

3. Mabey D. Epidemiology of STIs: worldwide. Am J Med. 2010; 38:216–219.

4. Yeh JM, Hook EW 3rd, Golide SJ. A refined estimate of the average lifetime cost of pelvic inflammatory disease. Sex Transm Dis. 2003; 30:369–378. PMID: 12916126.

5. Yorke JA, Hethcote HW, Nold A. Dynamics and control of the transmission of gonorrhea. Sex Transm Dis. 1978; 5:51–56. PMID: 10328031.

6. Garnett GP, Bowden FJ. Epidemiology and control of curable sexually transmitted diseases: opportunities and problems. Sex Transm Dis. 2000; 27:588–599. PMID: 11099074.

7. Kretzschmar M, van Duynhoven YT, Severijnen AJ. Modeling prevention strategies for gonorrhea and Chlamydia using stochastic network simulations. Am J Epidemiol. 1996; 144:306–317. PMID: 8686700.

8. Stamm WE, Koutsky LA, Benedetti JK, Jourden JL, Brunham RC, Holmes KK. Chlamydia trachomatis urethral infections in men. Prevalence, risk factors, and clinical manifestations. Ann Intern Med. 1984; 100:47–51. PMID: 6546328.

9. Marrazzo JM, Whittington WL, Celum CL, Handsfield HH, Clark A, Cles L, et al. Urine-based screening for Chlamydia trachomatis in men attending sexually transmitted disease clinics. Sex Transm Dis. 2001; 28:219–225. PMID: 11318253.

10. Creighton S, Tenant-Flowers M, Taylor CB, Miller R, Low N. Co-infection with gonorrhoea and chlamydia: how much is there and what does it mean? Int J STD AIDS. 2003; 14:109–113. PMID: 12662389.

11. Brunham RC, Pourbohloul B, Mak S, White R, Rekart ML. The unexpected impact of a Chlamydia trachomatis control program on susceptibility to reinfection. J Infect Dis. 2005; 192:1836–1844. PMID: 16235186.

12. Barnes RC, Rompalo AM, Stamm WE. Comparison of Chlamydia trachomatis serovars causing rectal and cervical infections. J Infect Dis. 1987; 156:953–958. PMID: 3680995.

13. Weinstock H, Berman S, Cates W Jr. Sexually transmitted diseases among American youth: Incidence and prevalence estimates, 2000. Perspect Sex Reprod Health. 2004; 36:6–10. PMID: 14982671.

14. McMillan A, Sommerville RG, McKie PM. Chlamydial infection in homosexual men: Frequency of isolation of Chlamydia trachomatis from the urethra, ano-rectum, and pharynx. Br J Vener Dis. 1981; 57:47–49. PMID: 7470835.

15. Miller WC, Ford CA, Morris M, Handcock MS, Schmitz JL, Hobbs MM, et al. Prevalence of chlamydial and gonococcal infections among young adults in the United States. JAMA. 2004; 291:2229–2236. PMID: 15138245.

16. Quinn TC, Goodell SE, Mkrtichian E, Schuffler MD, Wang SP, Stamm WE, et al. Chlamydia trachomatis proctitis. N Engl J Med. 1981; 305:195–200. PMID: 7017409.

17. Jones RB, Rabinovitch RA, Katz BP, Batteiger BE, Quinn TS, Terho P, et al. Chlamydia trachomatis in the pharynx and rectum of heterosexual patients at risk for genital infection. Ann Intern Med. 1985; 102:757–762. PMID: 3888022.

18. Lyss SB, Kamb ML, Peterman TA, Moran JS, Newman DR, Bolan G, et al. Chlamydia trachomatis among patients infected with and treated for Neisseria gonorrhoeae in sexually transmitted disease clinics in the United States. Ann Intern Med. 2003; 139:178–185. PMID: 12899585.

19. Korenromp EL, Sudaryo MK, de Vlas SJ, Gray RH, Sewankambo NK, Serwadda D, et al. What proportion of episodes of gonorrhoea and chlamydia becomes symptomatic? Int J STD AIDS. 2002; 13:91–101. PMID: 11839163.

20. Handsfield HH, Alexander ER, Pin Wang S, Pedersen AH, Holmes KK. Differences in the therapeutic response of chlamydia positive and chlamydia-negative forms of nongonococcal urethritis. J Am Vener Dis Assoc. 1976; 2:5–9. PMID: 767309.

21. Hillis SD, Coles FB, Litchfield B, Black CM, Mojica B, Schmitt K, et al. Doxycycline and azithromycin for prevention of chlamydial persistence or recurrence one month after treatment in women. A use-effectiveness study in public health settings. Sex Transm Dis. 1998; 25:5–11. PMID: 9437777.

22. Shafer MA, Schachter J, Moncada J, Keogh J, Pantell R, Gourlay L, et al. Evaluation of urine based screening strategies to detect Chlamydia trachomatis among sexually active asymptomatic young males. JAMA. 1993; 270:2065–2070. PMID: 8411573.

23. Oriel JD, Reeve P, Thomas BJ, Nicol CS. Infection with Chlamydia group A in men with urethritis due to Neisseria gonorrhoeae. J Infect Dis. 1975; 131:376–382. PMID: 804022.

24. Holmes KK, Handsfield HH, Wang SP, Wentworth BB, Turck M, Anderson JB, et al. Etiology of nongonococcal urethritis. N Engl J Med. 1975; 292:1199–1205. PMID: 165407.

25. Berger RE, Alexander ER, Harnisch JP, Paulsen CA, Monda GD, Ansell J, et al. Etiology, manifestations and therapy of acute epididymitis: Prospective study of 50 cases. J Urol. 1979; 121:750–754. PMID: 379366.

26. Kousa M, Saikku P, Richmond S, Lassus A. Frequent association of chlamydial infection with Reiter's syndrome. Sex Transm Dis. 1978; 5:57–61. PMID: 10328032.

27. Paavonen J, Stevens CE, Wølner-Hanssen P, Critchlow CW, Derouen T, Kiviat N, et al. Colposcopic manifestations of cervical and vaginal infections. Obstet Gynecol Surv. 1988; 43:373–381. PMID: 3419730.

28. Brunham RC, Paavonen J, Stevens CE, Kiviat N, Kuo CC, Critchlow CW, et al. Mucopurulent cervicitis-the ignored counterpart in women of urethritis in men. N Engl J Med. 1984; 311:1–6. PMID: 6427611.

29. Black CM. Current methods of laboratory diagnosis of Chlamydia trachomatis infections. Clin Microbiol Rev. 1997; 10:160–184. PMID: 8993862.

30. Marrazzo JM, Stamm WE. New approaches to the diagnosis, treatment, and prevention of chlamydial infection. Curr Clin Top Infect Dis. 1998; 18:37–59. PMID: 9779350.

31. Bauwens JE, Clark AM, Loeffelholz MJ, Herman SA, Stamm WE. Diagnosis of Chlamydia trachomatis urethritis in men by polymerase chain reaction assay of first-catch urine. J Clin Microbiol. 1993; 31:3013–3016. PMID: 8263188.

32. Bianchi A, Scieux C, Brunat N, Vexiau D, Kermanach M, Pezin P, et al. An evaluation of the polymerase chain reaction amplicor Chlamydia trachomatis in male urine and female urogenital specimens. Sex Transm Dis. 1994; 21:196–200. PMID: 7974069.

33. Arya OP, Hobson D, Hart CA, Bartzokas C, Pratt BC. Evaluation of ciprofloxacin 500 mg twice daily for one week in treating uncomplicated gonococcal chlamydial, and non-specific urethritis in men. Genitourin Med. 1986; 62:170–174. PMID: 2942454.

34. Hooton TM, Batteiger BE, Judson FN, Spruance SL, Stamm WE. Ofloxacin versus Doxycycline for treatment of cervical infection with Chlamydia trachomatis. Antimicrob Agents Chemother. 1992; 36:1144–1146. PMID: 1510408.

35. Ossewaarde JM, Plantema FH, Rieffe M, Nawrocki RP, de Vries A, van Loon AM. Efficacy of single-dose azithromycin versus doxycycline in the treatment of cervical infections caused by Chlamydia trachomatis. Eur J Clin Microbiol Infect Dis. 1992; 11:693–697. PMID: 1330565.

36. Bowie WR, Alexander ER, Stimson JB, Floyd JF, Holmes KK. Therapy for nongonococcal urethritis: Double-blind randomized comparison of two doses and two durations of minocycline. Ann Intern Med. 1981; 95:306–311. PMID: 7271091.

37. Prentice MJ, Taylor-Robinson D, Csonka GW. Non-specific urethritis: A placebo-controlled trial of minocycline in conjunction with laboratory investigations. Br J Vener Dis. 1976; 52:269–275. PMID: 786440.

38. Morton R. Rook A, editor. Gonorrhoea, Vol. 9 in the series Major Problems in Dermatology. 1977. London: W.B. Saunders.

39. Rosebury T. Microbes and morals: the strange story of venereal disease. 1971. New York: Viking Adult.

40. Kampmeier RH. Identification of the gonococcus by Albert Neisser. Sex Transm Dis. 1978; 5:71–72. PMID: 10328036.

41. Kampmeier RH. Introduction of sulfonamide therapy for gonorrhea. Sex Transm Dis. 1983; 10:81–84. PMID: 6362039.

42. Laga M, Manoka A, Kivuvu M, Malele B, Tuliza M, Nzila N, et al. Non-ulcerative sexually transmitted diseases as risk factors for HIV-1 transmission in women; results from a cohort study. AIDS. 1993; 7:95–102. PMID: 8442924.

43. Memish ZA, Osoba AO. Sexually transmitted diseases and travel. Int J Antimicrob Agents. 2003; 21:131–134. PMID: 12615376.

44. Fenton KA, Lowndes CM. Recent trends in the epidemiology of sexually transmitted infections in the European Union. Sex Transm Infect. 2004; 80:255–263. PMID: 15295121.

45. Centers for Disease Control and Prevention. Sexually Transmitted Diseases Surveillance, 2005. 2006. 11. Atlanta, GA. U.S. Department of Health and Human Services, Public Health Service.

46. 2006 World Health Organization. CISID database. Sexually transmitted infections. Accessed March 28, 2007. http://data.euro.who.int/cisid/default.aspx?TabID=123064.

47. Barnes RC, Holmes KK. Epidemiology of gonorrhea: Current perspectives. Epidemiol Rev. 1984; 6:1–30. PMID: 6436045.

48. Lafferty WE, Hughes JP, Handsfield HH. Sexually transmitted disease in men who have sex with men: Acquisition of gonorrhea and nongonococcal urethritis by fellatio and implications for STD/HIV prevention. Sex Transm Dis. 1997; 24:272–278. PMID: 9153736.

49. Kellogg DS Jr, Peacock WL Jr, Deacon WE, Brown L, Pirkle DI. Neisseria gonorrhoeae. I. Virulence genetically linked to clonal variation. J Bacteriol. 1963; 85:1274–1279. PMID: 14047217.

50. Bruins SC, Tight RR. Laboratory-acquired gonococcal conjunctivitis. JAMA. 1979; 241:274. PMID: 102807.

51. Pearce WA, Buchanan TM. Attachment role of gonococcal pili: Optimum conditions and quantitation of adherence of isolated pili to human cells in vitro. J Clin Invest. 1978; 61:931–943. PMID: 96134.

52. King GJ, Swanson J. Studies on gonococcus infection. XV. Identification of surface proteins of Neisseria gonorrhoeae correlated with leukocyte association. Infect Immun. 1978; 21:575–584. PMID: 211086.

53. Holmes KK, Johnson DW, Trostle HJ. An estimate of the risk of men acquiring gonorrhea by sexual contact with infected females. Am J Epidemiol. 1970; 91:170–174. PMID: 5416250.

54. Hooper RR, Reynolds GH, Jones OG, Zaidi A, Wiesner PJ, Latimer KP, et al. Cohort study of venereal disease: 1. The risk of gonorrhea transmission from infected women to men. Am J Epidemiol. 1978; 108:136–144. PMID: 707474.

55. Tice RW, Rodriguez VL. Pharyngeal gonorrhea. JAMA. 1981; 246:2717–2719. PMID: 6796704.

56. Handsfield HH, Lipman TO, Harnisch JP, Tronca E, Holmes KK. Asymptomatic gonorrhea in men. Diagnosis, natural course, prevalence and significance. N Engl J Med. 1974; 290:117–123. PMID: 4202519.

57. Robinson AJ, Ridgway GL. Concurrent gonococcal and chlamydial infection: how best to treat. Drugs. 2000; 59:801–813. PMID: 10804036.

58. Harrison WO, Hooper RR, Wiesner PJ, Campbell AF, Karney WW, Reynolds GH, et al. A trial of minocycline given after exposure to prevent gonorrhea. N Engl J Med. 1979; 300:1074–1078. PMID: 107450.

59. Jacobs NF, Kraus SJ. Gonococcal and nongonococcal urethritis in men: Clinical and laboratory differentiation. Ann Intern Med. 1975; 82:7–12. PMID: 67816.

60. Barlow D, Phillips I. Gonorrhea in women: Diagnostic, clinical, and laboratory aspects. Lancet. 1978; 1:761–764. PMID: 76760.

61. Platt R, Rice PA, McCormack WM. Risk of acquiring gonorrhea and prevalence of abnormal adnexal findings among women recently exposed to gonorrhea. JAMA. 1983; 250:3205–3209. PMID: 6417362.

62. Curran JW, Rendtorff RC, Chandler RW, Wiser WL, Robinson H. Female gonorrhea: Its relation to abnormal uterine bleeding, urinary tract symptoms, and cervicitis. Obstet Gynecol. 1975; 45:195–198. PMID: 804148.

63. Lebedeff DA, Hochman EB. Rectal gonorrhea in men: Diagnosis and treatment. Ann Intern Med. 1980; 92:463–466. PMID: 6767428.

64. Wiesner PJ, Tronca E, Bonin P, Pedersen AH, Holmes KK. Clinical spectrum of pharyngeal gonococcal infections. N Engl J Med. 1973; 288:181–185. PMID: 4264580.

65. Hutt DM, Judson FN. Epidemiology and treatment of oropharyngeal gonorrhea. Ann Intern Med. 1986; 104:655–658. PMID: 2938529.

66. Johnson RE, Newhall WJ, Papp JR, Knapp JS, Black CM, Gift TL, et al. Screening tests to detect Chlamydia trachomatis and Neisseria gonorrhoeae infections - 2002. MMWR Recomm Rep. 2002; 51:1–38. PMID: 12418541.

67. Cook RL, Hutchison SL, Østergaard L, Braithwaite RS, Ness RB. Systematic review: Noninvasive testing for chlamydia trachomatis and Neisseria gonorrhoeae. Ann Intern Med. 2005; 142:914–925. PMID: 15941699.

68. Koumans EH, Johnson RE, Knapp JS, St Louis ME. Laboratory testing for Neisseria gonorrhoeae by recently introduced nonculture tests: a performance review with clinical and public health considerations. Clin Infect Dis. 1998; 27:1171–1180. PMID: 9827265.

69. Davies PO, Low N, Ison CA. The role of effective diagnosis for the control of gonorrhoea in high prevalence populations. Int J STD AIDS. 1998; 9:435–443. PMID: 9702590.

70. Boslego JW, Tramont EC, Takafuji ET, Diniega BM, Mitchell BS, Small JW, et al. Effect of spectinomycin use on the prevalence of spectinomycin-resistant and of penicillinase-producing Neisseria gonorrhoeae. N Engl J Med. 1987; 317:272–278. PMID: 2955222.

71. Burstein GR, Berman SM, Blumer JL, Moran JS. Ciprofloxacin for the treatment of uncomplicated gonorrhea infection in adolescents: does the benefit outweigh the risk? Clin Infect Dis. 2002; 35(suppl 2):S191–S199. PMID: 12353206.

72. Handsfield HH, Dalu ZA, Martin DH, Douglas JM Jr, McCarty JM, Schlossberg D. Azithromyclin Gonorrhea Study Group. Multicenter trial of single-dose azithromycin vs. ceftriaxone in the treatment of uncomplicated gonorrhea. Sex Transm Dis. 1994; 21:107–111. PMID: 9071422.

73. Paster BJ, Dewhirst FE. Phylogenetic foundation of spirochetes. J Mol Microbiol Biotechnol. 2000; 2:341–344. PMID: 11075904.

74. Garnett GP, Aral SO, Hoyle DV, Cates W Jr, Anderson RM. The natural history of syphilis. Implications for the transmission dynamics and control of infection. Sex Transm Dis. 1997; 24:185–120. PMID: 9101629.

75. Klausner JD, Wolf W, Fischer-Ponce L, Zolt I, Katz MH. Tracing a syphilis outbreak through cyberspace. JAMA. 2000; 284:447–449. PMID: 10904507.

76. Ratnam S. The laboratory diagnosis of syphilis. Can J Infect Dis Med Microbiol. 2005; 16:45–51. PMID: 18159528.

77. Nandwani R, Evans DT. Are you sure it's syphilis? A review of false positive serology. Int J STD AIDS. 1995; 6:241–248. PMID: 7548285.

78. Romanowski B, Sutherland R, Fick GH, Mooney D, Love EJ. Serologic response to treatment of infectious syphilis. Ann Intern Med. 1991; 114:1005–1009. PMID: 2029095.

79. Mackay IM, Harnett G, Jeoffreys N, Bastian I, Sriprakash KS, Siebert D, et al. Detection and discrimination of herpes simplex viruses, Haemophilus ducreyi, Treponema pallidum, and Calymmatobacterium (Klebsiella) granulomatis from genital ulcers. Clin Infect Dis. 2006; 42:1431–1438. PMID: 16619156.

80. Turner TB, Hardy PH, Newman B. Infectivity tests in syphilis. Br J Vener Dis. 1969; 45:183–195. PMID: 4899592.

81. Bauer TJ, Price EV, Cutler JC. Spinal fluid examinations among patients with primary or secondary syphilis. Am J Syph. 1952; 36:309–318. PMID: 14933675.

82. Hook EW 3rd, Marra CM. Acquired syphilis in adults. N Engl J Med. 1992; 326:1060–1069. PMID: 1549153.

83. Rolfs RT, Joesoef MR, Hendershot EF, Rompalo AM, Augenbraun MH, Chiu M, et al. The Syphilis and HIV Study Group. A randomized trial of enhanced therapy for early syphilis in patients with and without human immunodeficiency virus infection. N Engl J Med. 1997; 337:307–314. PMID: 9235493.

84. Golden MR, Marra CM, Holmes KK. Update on syphilis: resurgence of an old problem. JAMA. 2003; 290:1510–1514. PMID: 13129993.

85. Brown ST. Adverse reactions in syphilis therapy. J Am Vener Dis Assoc. 1976; 3:172–176. PMID: 1010785.

86. Zhou P, Gu Z, Xu J, Wang X, Liao K. A study evaluating ceftriaxone as a treatment agent for primary and secondary syphilis in pregnancy. Sex Transm Dis. 2005; 32:495–498. PMID: 16041252.

87. Ghanem KG, Erbelding EJ, Cheng WW, Rompalo AM. Doxycycline compared with benzathine penicillin for the treatment of early syphilis. Clin Infect Dis. 2006; 42:e45–e49. PMID: 16477545.

88. Riedner G, Rusizoka M, Todd J, Maboko L, Hoelscher M, Mmbando D, et al. Single-dose azithromycin versus penicillin G benzathine for the treatment of early syphilis. N Engl J Med. 2005; 353:1236–1244. PMID: 16177249.

89. Lukehart SA. Serologic testing after therapy for syphilis: is there a test for cure? Ann Intern Med. 1991; 114:1057–1058. PMID: 2029102.

90. Ghanem KG, Erbelding EJ, Wiener ZS, Rompalo AM. Serological response to syphilis treatment in HIV-positive and HIV-negative patients attending sexually transmitted diseases clinics. Sex Transm Infect. 2007; 83:97–101. PMID: 16943224.

91. Centers for Disease Control and Prevention. Workowski KA, Berman SM. Sexually transmitted diseases treatment guidelines, 2006. MMWR Recomm Rep. 2006; 55:1–94. PMID: 16888612.

92. Morse SA. Chancroid and Haemophilus ducreyi. Clin Microbiol Rev. 1989; 2:137–157. PMID: 2650859.

93. Hammond GW, Slutchuk M, Scatliff J, Sherman E, Wilt JC, Ronald AR. Epidemiologic, clinical, laboratory, and therapeutic features of an urban outbreak of chancroid in North America. Rev Infect Dis. 1980; 2:867–879. PMID: 6971469.

94. Lewis D. Chancroid: clinical manifestations, diagnosis and management. Sex Transm Infect. 2003; 79:68–71. PMID: 12576620.

95. Tyndall MW, Agoki E, Plummer FA, Malisa W, Ndinya-Achola JO, Ronald AR. Single dose azithromycin for the treatment of chancroid: a randomized comparison with erythromycin. Sex Transm Dis. 1994; 21:231–234. PMID: 7974076.

96. Martin DH, Sargent SJ, Wendel GD Jr, McCormack WM, Spier NA, Johnson RB. Comparison of azithromycin and ceftriaxone for the treatment of chancroid. Clin Infect Dis. 1995; 21:409–414. PMID: 8562752.